Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)

M. M. Morrison; M. M. Williams; D. B. Vaught; D. Hicks; J. Lim; C. McKernan; L. Aurisicchio; G. Ciliberto; C. Simion; C. Sweeney; R. S. Cook

doi:10.1038/onc.2015.418

Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)

M. M. Morrison, M. M. Williams, D. B. Vaught, D. Hicks, J. Lim, C. McKernan, L. Aurisicchio, G. Ciliberto, C. Simion, C. Sweeney, R. S. Cook

Biochemistry and Molecular Medicine

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English (US)
Pages (from-to)	1206
Number of pages	1
Journal	Oncogene
Volume	35
Issue number	9
DOIs	https://doi.org/10.1038/onc.2015.418
State	Published - Mar 3 2016

ASJC Scopus subject areas

Molecular Biology
Cancer Research
Genetics

Cite this

Morrison, M. M., Williams, M. M., Vaught, D. B., Hicks, D., Lim, J., McKernan, C., Aurisicchio, L., Ciliberto, G., Simion, C., Sweeney, C., & Cook, R. S. (2016). Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169). Oncogene, 35(9), 1206. https://doi.org/10.1038/onc.2015.418

Erratum : Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169). / Morrison, M. M.; Williams, M. M.; Vaught, D. B.; Hicks, D.; Lim, J.; McKernan, C.; Aurisicchio, L.; Ciliberto, G.; Simion, C.; Sweeney, C.; Cook, R. S.

In: Oncogene, Vol. 35, No. 9, 03.03.2016, p. 1206.

Research output: Contribution to journal › Comment/debate

Morrison, MM, Williams, MM, Vaught, DB, Hicks, D, Lim, J, McKernan, C, Aurisicchio, L, Ciliberto, G, Simion, C, Sweeney, C & Cook, RS 2016, 'Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)', Oncogene, vol. 35, no. 9, pp. 1206. https://doi.org/10.1038/onc.2015.418

Morrison, M. M. ; Williams, M. M. ; Vaught, D. B. ; Hicks, D. ; Lim, J. ; McKernan, C. ; Aurisicchio, L. ; Ciliberto, G. ; Simion, C. ; Sweeney, C. ; Cook, R. S. / Erratum : Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169). In: Oncogene. 2016 ; Vol. 35, No. 9. pp. 1206.

@article{3c3ec702e5fd4893be30c6985f0d3028,

title = "Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)",

author = "Morrison, {M. M.} and Williams, {M. M.} and Vaught, {D. B.} and D. Hicks and J. Lim and C. McKernan and L. Aurisicchio and G. Ciliberto and C. Simion and C. Sweeney and Cook, {R. S.}",

year = "2016",

month = mar

day = "3",

doi = "10.1038/onc.2015.418",

language = "English (US)",

volume = "35",

pages = "1206",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)

AU - Morrison, M. M.

AU - Williams, M. M.

AU - Vaught, D. B.

AU - Hicks, D.

AU - Lim, J.

AU - McKernan, C.

AU - Aurisicchio, L.

AU - Ciliberto, G.

AU - Simion, C.

AU - Sweeney, C.

AU - Cook, R. S.

PY - 2016/3/3

Y1 - 2016/3/3

UR - http://www.scopus.com/inward/record.url?scp=84959470497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959470497&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.418

DO - 10.1038/onc.2015.418

M3 - Comment/debate

AN - SCOPUS:84959470497

VL - 35

SP - 1206

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 9

ER -

Access to Document

10.1038/onc.2015.418